Company Research Snapshots
Concise overviews of public biotech companies, including pipeline assets, therapeutic focus, clinical stage, recent filings, and key risks.
Our Services
Independent biotech research for undercovered healthcare companies.
Frisby Research provides independent biotech research focused on nanocap and small-cap healthcare companies.
Catalyst Monitoring
Tracking of upcoming clinical, regulatory, financing, and corporate events that may affect healthcare companies.
Cash Runway and Financing-Risk Analysis
Review of SEC filings, cash balances, burn rates, runway estimates, shelf registrations, ATM facilities, and potential dilution risk.
Clinical Trial and Pipeline Tracking
Monitoring of ClinicalTrials.gov records, trial status changes, enrollment updates, primary completion dates, and development timelines.
Biology-Aware Research
Scientific analysis of drug targets, mechanisms of action, disease rationale, biomarkers, and translational risk.
Watchlists and Alerts
Private research tools for tracking selected companies, sectors, modalities, and upcoming catalysts.
Deep-Dive Reports
Institutional-style research reports covering company strategy, scientific rationale, clinical development, competitive positioning, and financial risk.
Bespoke Biotech Diligence
Custom research projects for investors, analysts, and healthcare professionals seeking deeper assessment of specific companies, assets, indications, or therapeutic areas.
How engagements work
- Custom research subscriptions for investors focused on nanocap biotech.
- Ongoing catalyst monitoring and watchlist maintenance for active portfolios.
- Private client portal access for reports, rankings, and follow-up notes.